abstract |
The present invention relates to a fusion protein and the use of the fusion protein (or a genetic construct or vector encoding such a fusion protein) for vaccinating against a viral infection. The present invention extends to pharmaceutical compositions comprising such fusion proteins or constructs for preventing and treating viral infections, and methods and uses thereof. |